The N-methyl-D-aspartate receptor channel blocker amantadine does not cause histopathological alterations in human brain tissue

Acta Neuropathologica

Volumn 98, Issue 1, 1999, Pages 85-90

  Kornhuber, Johannes ^a   Jellinger, Kurt ^b   Wiltfang, Jens ^a   Leblhuber, Fritz ^c   Riederer, Peter ^d  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^c Psychiatric Hospital   (Austria)

^d UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Amantadine; Human N methyl D aspartate; Phencyclidine; Postmortem brain

Indexed keywords

AMANTADINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SAFETY; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEWY BODY; NERVE DEGENERATION; NORMAL HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AMANTADINE; BRAIN; DOPAMINE AGENTS; FEMALE; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MALE; NEUROGLIA; NEURONS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0033057806     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010051054     Document Type: Article

References (40)

1. Allen HL, Iversen LL (1990) Phencyclidine, dizocilpine, and cerebrocortical neurons. Science 247 : 221
2. Auer RN (1996) Effect of age and sex on N-methyl-D-aspartate antagonist-induced neuronal necrosis in rats. Stroke 27 : 743-746
3. Auer RN (1997) Structural neurotoxicologic investigation of the glycine antagonist 5-nitro-6,7-dichloroquinoxalinedione (ACEA-1021). Neurotoxicology 18 : 53-62
4. Auer RN, Coulter KC (1994) The nature and time course of neuronal vacuolization induced by the N-methyl-D-aspartate antagonist MK-801. Acta Neuropathol 87 : 1-7
5. Auer RN, Coupland SG, Jason GW, Archer DP, Payne J, Belzberg AJ, Ohtaki M, Tranmer BI (1996) Postischemic therapy with MK-801 (dizocilpine) in a primate model of transient focal brain ischemia. Mol Chem Neuropathol 29 : 193-210
6. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82 : 239-259
7. Castrén E, Penha Berzaghi M da, Lindholm D, Thoenen H (1993) Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain. Exp Neurol 122 : 244-252
8. Danysz W, Parsons CG, Kornhuber J, Schmidt WJ, Quack G (1997) Aminoadamantanes as NMDA receptor antagonists and antiparkinsonian agents - preclinical studies. Neurosci Biobehav Rev 21 : 455-468
9. Duval D, Roome N, Gauffeny C, Nowicki JP, Scatton B (1992) SL 82.0715, an NMDA antagonist acting at the polyamine site, does not induce neurotoxic effects on rat conical neurons. Neurosci Lett 137 : 193-197
10. Farber NB, Price MT, Labruyere J, Nemnich J, St Peter H, Wozniak DF, Olney JW (1993) Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol Psychiatry 34 : 119-121
11. Farber NB, Wozniak DF, Price MT, Labruyere J, Huss J, St Peter H, Olney JW (1995) Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry 38 : 788-796
12. Fix AS, Wightman KA, O'Callaghan JP (1995) Reactive gliosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex: GFAP evaluation by sandwich ELISA and immunocytochemistry. Neurotoxicology 16 : 229-237
13. Fix AS, Wozniak DF, Truex LL, McEwen M, Miller JP, Olney JW (1995) Quantitative analysis of factors influencing neuronal necrosis induced by MK-801 in the rat posterior cingulate/retrosplenial cortex. Brain Res 696 : 194-204
14. Gass P, Herdegen T, Bravo R, Kiessling M (1993) Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience 53 : 749-758
15. Gsell W, Lange KW, Pfeuffer R, Heckers S, Heinsen H, Senitz D, Jellinger K, Ransmayr G, Wichart I, Vock R, Beckmann H, Riederer P (1993) How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm Suppl 39 : 31-70
16. Hawkinson JE, Huber KR, Sahota PS, Han Hsu H, Weber E, Whitehouse MJ (1997) The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain. Brain Res 744 : 227-234
17. Hetman M, Danysz W, Kaczmarek L (1997) Increased expression of cathepsin D in retrosplenial cortex of MK-801-treated rats. Exp Neurol 147 : 229-237
18. Izumisawa N, Kawakami A, Ohata T, Hanada T, Okeda R (1995) YM90K, an AMPA antagonist, has no neurotoxic effects on cerebrocortical neurons in rats. Exp Neurol 134 : 199-204
19. Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N, Zorumski CF, Olney JW (1998) Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nat Med 4 : 460-463
20. Kakkar R, Raju RV, Rajput AH, Sharma RK (1997) Amantadine: an antiparkinsonian agent inhibits bovine brain 60 kDa calmodulin-dependent cyclic nucleotide phosphodiesterase isozyme. Brain Res 749 : 290-294
21. Kornhuber J, Weller M (1997) Psychotogenicity and NMDA receptor antagonism: implications for neuroprolective pharmacotherapy. Biol Psychiatry 41 : 135-144
22. Kornhuber J, Bormann J, Hübers M, Rusche K, Riederer P (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Eur J Pharmacol Mol Pharmacol Sect 206 : 297-300
23. Kornhuber J, Schoppmeyer K, Riederer P (1993) Affinity of 1-aminoadamantanes for the σ binding site in post-mortem human frontal cortex. Neurosci Lett 163 : 129-131
24. Kornhuber J, Weller M, Schoppmeyer K, Riederer P (1994) Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties. J Neural Transm Suppl 43 : 91-104
25. Kornhuber J. Quack G, Danysz W, Jellinger K, Danielczyk W, Gsell W, Riederer P (1995) Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 34 : 713-721
26. Matsubayashi H, Swanson KL, Albuquerque EX (1997) Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons. J Pharmacol Exp Ther 281 : 834-844
27. McCulloch J, Iversen LL (1991) Autoradiographic assessment of the effects of N-methyl-D-aspartate (NMDA) receptor antagonists in vivo. Neurochem Res 16 : 951-963
28. McKeith LG, Galasko D, Kosaka K, et al (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 : 1113-1124
29. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 : 479-486
30. Näkki R, Nickolenko J, Chang J, Sagar SM, Sharp FR (1996) Haloperidol prevents ketamine- and phencyclidine-induced HSP70 protein expression but not microglial activation. Exp Neurol 137 : 234-241
31. Olney JW, Labruyere J, Price MT (1989) Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244 : 1360-1362
32. Olney JW, Labruyere J, Price MT (1990) Phencyclidine, dizocilpine, and cerebrocortical neurons. Science 247 : 221
33. Olney JW, Labruyere J, Wang G, Wozniak DF, Price MT, Sesma MA (1991) NMDA antagonist neurotoxicity: mechanism and prevention. Science 254 : 1515-1518
34. Parsons CG, Quack G, Bresink L, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W (1995) Comparison of the potency, kinetics and voltage-dependency of open channel blockade for a series of uncompetitve NMDA antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Neuropharmacology 34 : 1239-1258
35. Price MT, Farber NB, Labruyere J, Foster J, Olney JW (1994) Tracing the circuitry that mediates NMDA antagonist neurotoxicity. Soc Neurosci Abstr 20 : 1532
36. Raboisson P, Flood K, Lehmann A, Berge OG (1997) MK-801 neurotoxicity in the guinea pig cerebral cortex: susceptibility and regional differences compared with the rat. J Neurosci Res 49 : 364-371
37. Sharp FR, Jasper P, Hall J, Noble L, Sagar SM (1991) MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol 30 : 801-809
38. Sharp FR, Butman M, Wang S, Koistinaho J, Graham SH, Sagar SM, Noble L, Berger P, Longo FM (1992) Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine. J Neurosci Res 33 : 605-616
39. Sharp FR, Butman M, Wang S, Koistinaho J, Graham SH, Sagar SM, Berger P, Longo FM (1993) Heat shock proteins used to show that haloperidol prevents neuronal injury produced by ketamine, MK801, and phencyclidine. Ann N Y Acad Sci 679 : 288-290
40. Tomitaka S, Hashimoto K, Narita N, Sakamoto A, Minabe Y, Tamura A (1996) Memantine induces heat shock protein HSP70 in the posterior cingulate cortex, retrosplenial cortex and dentate gyrus of rat brain. Brain Res 740 : 1-5